Detection of interferon alpha protein reveals differential levels and cellular sources in disease

Journal of Experimental Medicine

Volumn 214, Issue 5, 2017, Pages 1547-1555

  Rodero, Mathieu P ^a   Decalf, Jérémie ^c,d   Bondet, Vincent ^c,d   Hunt, David ^e,f   Rice, Gillian I ^g   Werneke, Scott ^c,d   McGlasson, Sarah L ^e,f   Alyanakian, Marie Alexandra ⁱ   Bader Meunier, Brigitte ^i,j   Barnerias, Christine ⁱ   Bellon, Nathalia ⁱ   Belot, Alexandre ^k   Bodemer, Christine ^b,i   Briggs, Tracy A ^g,h   Desguerre, Isabelle ⁱ   Frémond, Marie Louise ^a   Hully, Marie ⁱ   van den Maagdenberg, Arn M J M ^l   Melki, Isabelle ^a,i,m   Meyts, Isabelle ^n,o   Musset, Lucile ^p   Pelzer, Nadine ^l   Quartier, Pierre ^b,i   Terwindt, Gisela M ^l   Wardlaw, Joanna ^f   Wiseman, Stewart ^f   Rieux Laucat, Frédéric ^b,j   Rose, Yoann ^a   Neven, Bénédicte ^b,i,j   Hertel, Christina ^q   Hayday, Adrian ^r,s   Albert, Matthew L ^c,d   Rozenberg, Flore ^b   Crow, Yanick J ^a,b,g,i   Duffy, Darragh ^c,d   more..

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT PASTEUR   (France)

^d INSTITUT PASTEUR   (France)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h ST MARY S HOSPITAL   (United Kingdom)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j INSEM UMR 1163 Laboratory of Normal and Pathological Homeostasis of the Immune System   (France)

^k HOSPICES CIVILS DE LYON   (France)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m HÔPITAL ROBERT DEBRÉ   (France)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^o UNIVERSITY OF LEUVEN   (Belgium)

^p PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^q ImmunoQure   (Germany)

^r GUY S HOSPITAL   (United Kingdom)

^s THE FRANCIS CRICK INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON REGULATORY FACTOR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CEREBROSPINAL FLUID; IMMUNOLOGY; METABOLISM; PROCEDURES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE; VESICULAR STOMATITIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; VESICULAR STOMATITIS;

EID: 85021075354     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20161451     Document Type: Article

References (25)

1. Berger Rentsch, M., and G. Zimmer. 2011. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS One. 6:e25858. http ://dx .doi .org/10 .1371/journal .pone .0025858
2. Conrad, C.D., J.D. Domizio, A. Mylonas, C. Belkhodja, O. Demaria, A. Navarini, A.-K. Lapointe, L. French, M. Vernez, and M. Gilliet. 2015. ID: 2: Paradoxical psoriasis-Unabated type I IFN production induced by TNF blockade. Cytokine. 76:66-112. http ://dx .doi .org/10 .1016/j .cyto .2015 .08 .045
3. Crow, Y.J. 2011. Type I interferonopathies: A novel set of inborn errors of immunity. Ann. N. Y. Acad. Sci. 1238:91-98. http ://dx .doi .org/10 .1111/j .1749-6632 .2011 .06220 .x
4. Greenberg, S.A., J.L. Pinkus, G.S. Pinkus, T. Burleson, D. Sanoudou, R. Tawil, R.J. Barohn, D.S. Saperstein, H.R. Briemberg, M. Ericsson, et al. 2005. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57:664-678. http ://dx .doi .org/10 .1002/ana .20464
5. Hooks, J.J., H.M. Moutsopoulos, S.A. Geis, N.I. Stahl, J.L. Decker, and A.L. Notkins. 1979. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301:5-8. http ://dx .doi .org/10 .1056/NEJM197907053010102
6. Hua, J., K. Kirou, C. Lee, and M.K. Crow. 2006. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 54:1906-1916. http ://dx .doi .org/10 .1002/art .21890
7. Hunt, D., D. Kavanagh, I. Drummond, B. Weller, C. Bellamy, J. Overell, S. Evans, A. Jackson, and S. Chandran. 2014. Thrombotic microangiopathy associated with interferon beta. N. Engl. J. Med. 370:1270-1271. http ://dx .doi .org/10 .1056/NEJMc1316118
8. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147:258-267. http ://dx .doi .org/10 .1098/rspb .1957 .0048
9. Isaacs, A., J. Lindenmann, and R.C. Valentine. 1957. Virus interference. II. Some properties of interferon. Proc. R. Soc. Lond. B Biol. Sci. 147:268-273. http ://dx .doi .org/10 .1098/rspb .1957 .0049
10. Lauwerys, B.R., J. Ducreux, and F.A. Houssiau. 2014. Type I interferon blockade in systemic lupus erythematosus: where do we stand?. Rheumatology (Oxford). 53:1369-1376. http ://dx .doi .org/10 .1093/rheumatology/ket403
11. Lebon, P., G. Ponsot, J. Aicardi, F. Goutières, and M. Arthuis. 1979. Early intrathecal synthesis of interferon in herpes encephalitis. Biomedicine. 31:267-271
12. Lebon, P., J. Badoual, G. Ponsot, F. Goutières, F. Hémeury-Cukier, and J. Aicardi. 1988. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J. Neurol. Sci. 84:201-208. http ://dx .doi .org/10 .1016/0022-510X(88)90125-6
13. Li, Y., P.Y. Lee, E.S. Kellner, M. Paulus, J. Switanek, Y. Xu, H. Zhuang, E.S. Sobel, M.S. Segal, M. Satoh, and W.H. Reeves. 2010. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus. Arthritis Res. Ther. 12:R90. http ://dx .doi .org/10 .1186/ar3017
14. Manry, J., G. Laval, E. Patin, S. Fornarino, Y. Itan, M. Fumagalli, M. Sironi, M. Tichit, C. Bouchier, J.L. Casanova, et al. 2011. Evolutionary genetic dissection of human interferons. J. Exp. Med. 208:2747-2759. http ://dx .doi .org/10 .1084/jem .20111680
15. Meyer, S., M. Woodward, C. Hertel, P. Vlaicu, Y. Haque, J. Kärner, A. Macagno, S.C. Onuoha, D. Fishman, H. Peterson, et al. APE CED patient collaborative. 2016. AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies. Cell. 166:582-595. http ://dx .doi .org/10 .1016/j .cell .2016 .06 .024
16. Niewold, T.B., S.N. Kariuki, G.A. Morgan, S. Shrestha, and L.M. Pachman. 2009. Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum. 60:1815-1824. http ://dx .doi .org/10 .1002/art .24555
17. Palmer, P., M.G. Tovey, F. Raschilas, L. Brassart, J.F. Meritet, R. Porcher, and P. Lebon. 2007. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and nonviral inducing factors. Eur. Cytokine Netw. 18:108-114. http ://dx .doi .org/10 .1684/ecn .2007 .0093
18. Rice, G.I., G.M. Forte, M. Szynkiewicz, D.S. Chase, A. Aeby, M.S. Abdel-Hamid, S. Ackroyd, R. Allcock, K.M. Bailey, U. Balottin, et al. 2013. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNA SEH2A, RNA SEH2B, RNA SEH2C, SAM HD1, and ADAR: a case-control study. Lancet Neurol. 12:1159-1169. http ://dx .doi .org/10 .1016/S1474-4422(13)70258-8
19. Rice, G.I., I. Melki, M.-L. Frémond, T.A. Briggs, M.P. Rodero, N. Kitabayashi, A. Oojageer, B. Bader-Meunier, A. Belot, C. Bodemer, et al. 2017. Assessment of type I interferon signaling in pediatric inflammatory disease. J. Clin. Immunol. 37:123-132. http ://dx .doi .org/10 .1007/s10875-016-0359-1
20. Rissin, D.M., C.W. Kan, T.G. Campbell, S.C. Howes, D.R. Fournier, L. Song, T. Piech, P.P. Patel, L. Chang, A.J. Rivnak, et al. 2010. Singlemolecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28:595-599. http ://dx .doi .org/10 .1038/nbt .1641
21. Rodero, M.P., and Y.J. Crow. 2016. Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview. J. Exp. Med. 213:2527-2538. http ://dx .doi .org/10 .1084/jem .20161596
22. Seo, Y.J., G.H. Kim, H.J. Kwak, J.S. Nam, H.J. Lee, S.K. Suh, K.M. Baek, Y.W. Sohn, and S.H. Hong. 2009. Validation of a HeLa Mx2/Luc reporter cell line for the quantification of human type I interferons. Pharmacology. 84:135-144. http ://dx .doi .org/10 .1159/000235158
23. Siegal, F.P., N. Kadowaki, M. Shodell, P.A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y.J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1835-1837. http ://dx .doi .org/10 .1126/science .284 .5421 .1835
24. Wilson, D.H., D.M. Rissin, C.W. Kan, D.R. Fournier, T. Piech, T.G. Campbell, R.E. Meyer, M.W. Fishburn, C. Cabrera, P.P. Patel, et al. 2016. The Simoa HD-1 analyzer: A novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J. Lab. Autom. 21:533-547. http ://dx .doi .org/10 .1177/2211068215589580
25. Wiseman, S.J., M.E. Bastin, C.L. Jardine, G. Barclay, I.F. Hamilton, E. Sandeman, D. Hunt, E.N. Amft, S. Thomson, J.F. Belch, et al. 2016. Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus. Stroke. 47:2722-2728. http ://dx .doi .org/10 .1161/STR OKE AHA .116 .01433027703087